Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.

Hamadeh L, Enshaei A, Schwab C, Alonso CN, Attarbaschi A, Barbany G, den Boer ML, Boer JM, Braun M, Dalla Pozza L, Elitzur S, Emerenciano M, Fechina L, Felice MS, Fronkova E, Haltrich I, Heyman MM, Horibe K, Imamura T, Jeison M, Kovács G, Kuiper RP, Mlynarski W, Nebral K, Ivanov Öfverholm I, Pastorczak A, Pieters R, Piko H, Pombo-de-Oliveira MS, Rubio P, Strehl S, Stary J, Sutton R, Trka J, Tsaur G, Venn N, Vora A, Yano M, Harrison CJ, Moorman AV; International BFM Study Group.

Blood Adv. 2019 Jan 22;3(2):148-157. doi: 10.1182/bloodadvances.2018025718.

2.

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.

Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, Helsmoortel HH, Vermeulen J, Noguera R, Berbegall AP, Combaret V, Schleiermacher G, Laureys G, Schramm A, Schulte JH, Rahmann S, Bienertová-Vašků J, Mazánek P, Jeison M, Ash S, Hogarty MD, Moreno-Smith M, Barbieri E, Shohet J, Berthold F, Van Maerken T, Speleman F, Fischer M, De Preter K, Mestdagh P, Vandesompele J.

JCI Insight. 2018 Dec 6;3(23). pii: 97021. doi: 10.1172/jci.insight.97021.

3.

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.

Berbegall AP, Bogen D, Pötschger U, Beiske K, Bown N, Combaret V, Defferrari R, Jeison M, Mazzocco K, Varesio L, Vicha A, Ash S, Castel V, Coze C, Ladenstein R, Owens C, Papadakis V, Ruud E, Amann G, Sementa AR, Navarro S, Ambros PF, Noguera R, Ambros IM.

Br J Cancer. 2018 May;118(11):1502-1512. doi: 10.1038/s41416-018-0098-6. Epub 2018 May 14.

4.

miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.

Avigad S, Verly IR, Lebel A, Kordi O, Shichrur K, Ohali A, Hameiri-Grossman M, Kaspers GJ, Cloos J, Fronkova E, Trka J, Luria D, Kodman Y, Mirsky H, Gaash D, Jeison M, Avrahami G, Elitzur S, Gilad G, Stark B, Yaniv I.

Genes Chromosomes Cancer. 2016 Apr;55(4):328-39. doi: 10.1002/gcc.22334. Epub 2015 Dec 19.

PMID:
26684414
5.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4.

6.

MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma.

Feinberg-Gorenshtein G, Guedj A, Shichrur K, Jeison M, Luria D, Kodman Y, Ash S, Feinmesser M, Edry L, Shomron N, Weizman A, Yaniv I, Avigad S.

PLoS One. 2013 Nov 1;8(11):e78713. doi: 10.1371/journal.pone.0078713. eCollection 2013.

7.

Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.

Simon AJ, Lev A, Jeison M, Borochowitz ZU, Korn D, Lerenthal Y, Somech R.

J Clin Immunol. 2014 Jan;34(1):76-83. doi: 10.1007/s10875-013-9957-3. Epub 2013 Nov 7.

PMID:
24197801
8.

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.

Coenen EA, Zwaan CM, Reinhardt D, Harrison CJ, Haas OA, de Haas V, Mihál V, De Moerloose B, Jeison M, Rubnitz JE, Tomizawa D, Johnston D, Alonzo TA, Hasle H, Auvrignon A, Dworzak M, Pession A, van der Velden VH, Swansbury J, Wong KF, Terui K, Savasan S, Winstanley M, Vaitkeviciene G, Zimmermann M, Pieters R, van den Heuvel-Eibrink MM.

Blood. 2013 Oct 10;122(15):2704-13. doi: 10.1182/blood-2013-02-485524. Epub 2013 Aug 23.

9.

Genetic stratification of neuroblastoma for treatment tailoring.

Jeison M, Yaniv I, Ash S.

Future Oncol. 2011 Sep;7(9):1087-99. doi: 10.2217/fon.11.87. Review.

PMID:
21919696
10.

EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.

De Weer A, Van der Meulen J, Rondou P, Taghon T, Konrad TA, De Preter K, Mestdagh P, Van Maerken T, Van Roy N, Jeison M, Yaniv I, Cauwelier B, Noens L, Poirel HA, Vandenberghe P, Lambert F, De Paepe A, Sánchez MG, Odero M, Verhasselt B, Philippé J, Vandesompele J, Wieser R, Dastugue N, Van Vlierberghe P, Poppe B, Speleman F.

Br J Haematol. 2011 Aug;154(3):337-48. doi: 10.1111/j.1365-2141.2011.08737.x. Epub 2011 May 14.

PMID:
21569010
11.

Possible link between month of birth and childhood leukemia supports the hypothesis of an infectious etiology.

Yaniv I, Lewy H, Avrahami G, Jeison M, Stark B, Laron Z.

Isr Med Assoc J. 2010 Dec;12(12):776. No abstract available.

12.

A multilocus technique for risk evaluation of patients with neuroblastoma.

Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJ, Pötschger U, Ambros PF.

Clin Cancer Res. 2011 Feb 15;17(4):792-804. doi: 10.1158/1078-0432.CCR-10-0830.

13.

2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

Jeison M, Ash S, Halevy-Berko G, Mardoukh J, Luria D, Avigad S, Feinberg-Gorenshtein G, Goshen Y, Hertzel G, Kapelushnik J, Ben Barak A, Attias D, Steinberg R, Stein J, Stark B, Yaniv I.

Am J Pathol. 2010 Jun;176(6):2616-25. doi: 10.2353/ajpath.2010.090624. Epub 2010 Apr 15.

14.

Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.

Feinberg-Gorenshtein G, Avigad S, Jeison M, Halevy-Berco G, Mardoukh J, Luria D, Ash S, Steinberg R, Weizman A, Yaniv I.

Genes Chromosomes Cancer. 2009 Jul;48(7):539-43. doi: 10.1002/gcc.20662.

PMID:
19373781
15.

Minimal residual disease in peripheral blood stem cell harvests from high-risk neuroblastoma patients.

Avigad S, Feinberg-Gorenshtein G, Luria D, Jeison M, Stein J, Grunshpan A, Sverdlov Y, Ash S, Yaniv I.

J Pediatr Hematol Oncol. 2009 Jan;31(1):22-6. doi: 10.1097/MPH.0b013e31818e532c.

PMID:
19125082
16.

Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.

Avigad S, Naumov I, Ohali A, Jeison M, Berco GH, Mardoukh J, Stark B, Ash S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I.

Clin Cancer Res. 2007 Oct 1;13(19):5777-83.

17.

Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel.

Stark B, Jeison M, Gabay LG, Mardoukh J, Luria D, Bar-Am I, Avrahami G, Kapeliushnik Y, Sthoeger D, Herzel G, Steinberg DM, Cohen IJ, Goshen Y, Stein J, Zaizov R, Yaniv I.

Br J Haematol. 2004 Aug;126(3):320-37.

PMID:
15257704
18.

der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY).

Stark B, Jeison M, Glaser-Gabay L, Bar-Am I, Mardoukh J, Ash S, Atias D, Stein J, Zaizov R, Yaniv I.

Cancer Lett. 2003 Jul 18;197(1-2):75-9. Review.

PMID:
12880963
19.

Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins.

Stark B, Jeison M, Preudhomme C, Fenaux P, Ash S, Korek Y, Stein J, Zaizov R, Yaniv I.

Br J Haematol. 2002 Sep;118(4):1082-6.

PMID:
12199789
20.

Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.

Stark B, Jeison M, Bar-Am I, Glaser-Gabay L, Mardoukh J, Luria D, Feinmesser M, Goshen Y, Stein J, Abramov A, Zaizov R, Yaniv I.

Genes Chromosomes Cancer. 2002 Jul;34(3):313-24.

PMID:
12007192
21.

Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: detection by fluorescence in situ hybridization.

Stark B, Jeison M, Gobuzov R, Krug H, Glaser-Gabay L, Luria D, El-Hasid R, Harush MB, Avrahami G, Fisher S, Stein J, Zaizov R, Yaniv I.

Cancer Genet Cytogenet. 2001 Jul 15;128(2):108-13.

PMID:
11463448
22.

Is inversion 16 a prerequisite and id trisomy 22 invariably associated with inversion 16 in AML-M4eo?

Litmanovich D, Zamir-Brill R, Jeison M, Gershoni-Baruch R.

Cancer Genet Cytogenet. 2000 Aug;121(1):106. No abstract available.

PMID:
10991620
23.

Apparently unrelated clones shown by spectral karyotyping to represent clonal evolution of cryptic t(10;11)(p13;q23) in a patient with acute monoblastic leukemia.

Stark B, Jeison M, Gobuzov R, Finkelshtein S, Ash S, Avrahami G, Cohen IJ, Stein J, Yaniv I, Zaizov R, Bar-Am I.

Cancer Genet Cytogenet. 2000 Jul 15;120(2):105-10.

PMID:
10942799
24.

Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors.

Stark B, Mor C, Jeison M, Gobuzov R, Cohen IJ, Goshen Y, Stein J, Fisher S, Ash S, Yaniv I, Zaizov R.

J Neurooncol. 1997 Jan;31(1-2):3-8.

PMID:
9049824
25.

Metastatic extraosseous Ewing tumor. Association of the additional translocation der(16)t(1;16) with the variant EWS/ERG rearrangement in a case of cytogenetically inconspicuous chromosome 22.

Stark B, Zoubek A, Hattinger C, Jeison M, Gobuzov R, Mor C, Cohen I, Yaniv I, Ambros PF, Kovar H, Zaizov R.

Cancer Genet Cytogenet. 1996 Apr;87(2):161-6.

PMID:
8625264
26.

Dicentric (9;12) in pre-B acute lymphoblastic leukemia (ALL) in an infant.

Stark B, Jeison M, Luria D, Cohen IJ, Goshen Y, Fisher S, Zaizov R.

Leukemia. 1996 Jan;10(1):183-4. No abstract available.

PMID:
8558927
27.

A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature.

Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, Shaft D, Kodman Y, Gobuzov R, Ash S, et al.

Leuk Res. 1995 Jun;19(6):367-79. Review.

PMID:
7596149
28.

Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature.

Stark B, Jeison M, Shohat M, Goshen Y, Vogel R, Cohen IJ, Yaniv I, Kaplinsky C, Zaizov R.

Cancer Genet Cytogenet. 1994 Jul 1;75(1):11-22. Review.

PMID:
8039158

Supplemental Content

Loading ...
Support Center